Literature DB >> 18461556

Prostaglandin F2alpha induces the normoxic activation of the hypoxia-inducible factor-1 transcription factor in differentiating 3T3-L1 preadipocytes: Potential role in the regulation of adipogenesis.

Li Liu1, Neil A Clipstone.   

Abstract

Prostaglandin F2alpha (PGF2alpha) is a potent paracrine inhibitor of adipocyte differentiation. Here we show that treatment of differentiating 3T3-L1 preadipocytes with PGF2alpha induces the expression of DEC1, a transcriptional repressor that has previously been implicated in the inhibition of adipogenesis in response to hypoxia as a downstream effector of the hypoxia-inducible factor-1 (HIF-1) transcription factor. Surprisingly, despite performing our experiments under normal ambient oxygen conditions, we find that treatment of differentiating 3T3-L1 preadipocytes with PGF2alpha also results in the marked activation of HIF-1, as measured by an increase in the accumulation of the HIF-1alpha regulatory subunit. However, unlike the effects of hypoxia, this PGF2alpha-induced normoxic increase in HIF-1alpha is not mediated by an increase in the stability of the HIF-1alpha polypeptide, rather we find that PGF2alpha selectively increases the expression of the alternatively spliced HIF-1alpha I.1 mRNA isoform. Significantly, we demonstrate that the shRNA-mediated knockdown of endogenous HIF-1alpha expression attenuates the PGF2alpha-induced expression of DEC1, overcomes the inhibitory effects of PGF2alpha on the expression of proadipogenic transcription factors C/EBPalpha and PPARgamma and partially rescues the PGF2alpha-induced inhibition of adipogenesis. Taken together, these results indicate that PGF2alpha promotes the activation of the HIF-1 transcription factor pathway under normal oxygen conditions, and highlight a potential role for the normoxic activation of the HIF-1/DEC1-pathway in mediating the inhibitory effects of PGF2alpha on adipocyte differentiation. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18461556      PMCID: PMC2634301          DOI: 10.1002/jcb.21801

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  50 in total

1.  Dec1 and Dec2 are regulators of the mammalian molecular clock.

Authors:  Sato Honma; Takeshi Kawamoto; Yumiko Takagi; Katsumi Fujimoto; Fuyuki Sato; Mitsuhide Noshiro; Yukio Kato; Ken-ichi Honma
Journal:  Nature       Date:  2002-10-24       Impact factor: 49.962

2.  A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells.

Authors:  Xingming Shi; Weibin Shi; Qingnan Li; Buer Song; Mei Wan; Shuting Bai; Xu Cao
Journal:  EMBO Rep       Date:  2003-03-14       Impact factor: 8.807

3.  Effects of prolyl hydroxylase inhibitors on adipogenesis and hypoxia inducible factor 1 alpha levels under normoxic conditions.

Authors:  Z Elizabeth Floyd; Gail Kilroy; Xiying Wu; Jeffrey M Gimble
Journal:  J Cell Biochem       Date:  2007-08-15       Impact factor: 4.429

4.  The Krüppel-like factor KLF2 inhibits peroxisome proliferator-activated receptor-gamma expression and adipogenesis.

Authors:  Sucharita Sen Banerjee; Mark W Feinberg; Masafumi Watanabe; Susan Gray; Richard L Haspel; Diane J Denkinger; Rodney Kawahara; Hans Hauner; Mukesh K Jain
Journal:  J Biol Chem       Date:  2002-11-07       Impact factor: 5.157

5.  Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms.

Authors:  Elisabeth L Pagé; Geneviève A Robitaille; Jacques Pouysségur; Darren E Richard
Journal:  J Biol Chem       Date:  2002-10-11       Impact factor: 5.157

6.  Cyclosporin A prevents the hypoxic adaptation by activating hypoxia-inducible factor-1alpha Pro-564 hydroxylation.

Authors:  Gisela D'Angelo; Eric Duplan; Paul Vigne; Christian Frelin
Journal:  J Biol Chem       Date:  2003-02-13       Impact factor: 5.157

7.  Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia.

Authors:  Zhong Yun; Heather L Maecker; Randall S Johnson; Amato J Giaccia
Journal:  Dev Cell       Date:  2002-03       Impact factor: 12.270

8.  Differential regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1 alpha in activated T lymphocytes.

Authors:  D Lukashev; C Caldwell; A Ohta; P Chen; M Sitkovsky
Journal:  J Biol Chem       Date:  2001-10-15       Impact factor: 5.157

9.  Calcineurin mediates the calcium-dependent inhibition of adipocyte differentiation in 3T3-L1 cells.

Authors:  Joel W Neal; Neil A Clipstone
Journal:  J Biol Chem       Date:  2002-09-25       Impact factor: 5.157

10.  Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha.

Authors:  Denise A Chan; Patrick D Sutphin; Nicholas C Denko; Amato J Giaccia
Journal:  J Biol Chem       Date:  2002-08-16       Impact factor: 5.157

View more
  4 in total

Review 1.  Antiobesity mechanisms of action of conjugated linoleic acid.

Authors:  Arion Kennedy; Kristina Martinez; Soren Schmidt; Susanne Mandrup; Kathleen LaPoint; Michael McIntosh
Journal:  J Nutr Biochem       Date:  2009-12-01       Impact factor: 6.048

2.  HIF-1α Activation Promotes Luteolysis by Enhancing ROS Levels in the Corpus Luteum of Pseudopregnant Rats.

Authors:  Zonghao Tang; Jiajie Chen; Zhenghong Zhang; Jingjing Bi; Renfeng Xu; Qingqiang Lin; Zhengchao Wang
Journal:  Oxid Med Cell Longev       Date:  2021-09-01       Impact factor: 6.543

3.  Depressed levels of prostaglandin F2α in mice lacking Akr1b7 increase basal adiposity and predispose to diet-induced obesity.

Authors:  Fanny E Volat; Jean-Christophe Pointud; Emilie Pastel; Béatrice Morio; Benoit Sion; Ghislaine Hamard; Michel Guichardant; Romain Colas; Anne-Marie Lefrançois-Martinez; Antoine Martinez
Journal:  Diabetes       Date:  2012-07-30       Impact factor: 9.461

4.  Defects in the mitochondrial-tRNA modification enzymes MTO1 and GTPBP3 promote different metabolic reprogramming through a HIF-PPARγ-UCP2-AMPK axis.

Authors:  Rachid Boutoual; Salvador Meseguer; Magda Villarroya; Elena Martín-Hernández; Mohammed Errami; Miguel A Martín; Marta Casado; M-Eugenia Armengod
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.